First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - DRUG DEVELOPMENT SOLUTIONS LIMITED

ANALYSIS
Credit Risk Update: SECURED CREDITOR INFORMATION: DRUG DEVELOPMENT SOLUTIONS LIMITED, RESOLIAN NEWMARKET ROAD, FORDHAM, ELY, CB7 5WW. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 December 2022. The company was incorporated on 17 March 2022.

The accounts next due date is 30 September 2024. There is 1 mortgage, which is unsatisfied

The above was based on public record information as at 31 December 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 13985205
Date Incorporated: 17 March 2022
Date Latest Accounts: 31 December 2022
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: LGC RHODES LIMITED
Registered Number: 13985205
Annual Return: Unknown
Registered Office: RESOLIAN NEWMARKET ROAD, FORDHAM, ELY, CB7 5WW
SIC Code and Operations: 74909
SECURED CREDITORS
Number of Mortgages 1
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 1
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

DRUG DEVELOPMENT SOLUTIONS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 10 January 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
11438683 DRUG DISCOVERY AND DEVELOPMENT CONSULTANTS LTD Active
13199717 DRUG DISCOVERY CONSULTANTS LIMITED Active
SC494255 DRUG DISCOVERY DIRECTORY LTD Dissolved
09226743 DRUG DISCOVERY LIMITED Active
14211599 DRUG DISCOVERY SOLUTIONS LIMITED Active

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd